In early March 2020, just as the COVID-19 pandemic was forcing Duane Juang and other…
View More Faster, simpler COVID test offers hope for future pandemics while serving present needsHome »
A test that detects COVID-19 variants in your spit
With the Delta variant wreaking havoc on unvaccinated populations and COVID-19 cases spiking around the…
View More A test that detects COVID-19 variants in your spitBreath test to determine correct treatment for epilepsy
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a…
View More Breath test to determine correct treatment for epilepsyFaster test results mean better outcomes for HIV patients
Over the last 15 years, many African nations have made major strides towards enabling millions…
View More Faster test results mean better outcomes for HIV patientsA better molecular test to detect tuberculosis
The ‘Xpert Ultra’ molecular test has a greater capacity than its predecessor (‘Xpert MTB/RIF’) in…
View More A better molecular test to detect tuberculosisSimple urine test may help early detection of brain tumors
A recent study by Nagoya University researchers revealed that microRNAs in urine could be a…
View More Simple urine test may help early detection of brain tumorsOtters test positive for COVID-19, Georgia Aquarium says
CDC to meet to discuss J&J vaccine safety Harvard Global Health Institute director Dr. Ashish…
View More Otters test positive for COVID-19, Georgia Aquarium saysQiagen receives FDA emergency approval for coronavirus PCR test
FILE PHOTO: A logo of a testing company Qiagen is seen as Economy Minister Andreas…
View More Qiagen receives FDA emergency approval for coronavirus PCR testRoche to buy COVID test maker GenMark Diagnostics for $1.8 bn
Swiss pharma giant Roche said Monday it would pay $1.8 billion (1.5 billion euros) to…
View More Roche to buy COVID test maker GenMark Diagnostics for $1.8 bnFirst antigen test pilot in low prevalence COVID-19 settings signals challenges for rollout
Melbourne researchers who conducted a pilot to study the performance and feasibility of utilizing antigen…
View More First antigen test pilot in low prevalence COVID-19 settings signals challenges for rollout